271 related articles for article (PubMed ID: 8784643)
1. Synaptic effects of antidepressants.
Richelson E
J Clin Psychopharmacol; 1996 Jun; 16(3 Suppl 2):1S-7S; discussion 7S-9S. PubMed ID: 8784643
[TBL] [Abstract][Full Text] [Related]
2. Interactions of antidepressants with neurotransmitter transporters and receptors and their clinical relevance.
Richelson E
J Clin Psychiatry; 2003; 64 Suppl 13():5-12. PubMed ID: 14552650
[TBL] [Abstract][Full Text] [Related]
3. Monoamine neurocircuitry in depression and strategies for new treatments.
Hamon M; Blier P
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
[TBL] [Abstract][Full Text] [Related]
4. Role of norepinephrine in depression.
Delgado PL; Moreno FA
J Clin Psychiatry; 2000; 61 Suppl 1():5-12. PubMed ID: 10703757
[TBL] [Abstract][Full Text] [Related]
5. Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action.
Stahl SM
J Clin Psychiatry; 1998; 59 Suppl 4():5-14. PubMed ID: 9554316
[TBL] [Abstract][Full Text] [Related]
6. Biological basis of depression and therapeutic relevance.
Richelson E
J Clin Psychiatry; 1991 Jun; 52 Suppl():4-10. PubMed ID: 1646793
[TBL] [Abstract][Full Text] [Related]
7. Norepinephrine involvement in antidepressant action.
Frazer A
J Clin Psychiatry; 2000; 61 Suppl 10():25-30. PubMed ID: 10910014
[TBL] [Abstract][Full Text] [Related]
8. Possible neurobiological mechanisms underlying faster onset of antidepressant action.
Blier P
J Clin Psychiatry; 2001; 62 Suppl 4():7-11; discussion 37-40. PubMed ID: 11229789
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of action of antidepressants and therapeutic perspectives].
Bourin M; David DJ; Jolliet P; Gardier A
Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
[TBL] [Abstract][Full Text] [Related]
10. Antidepressants and brain neurochemistry.
Richelson E
Mayo Clin Proc; 1990 Sep; 65(9):1227-36. PubMed ID: 2169557
[TBL] [Abstract][Full Text] [Related]
11. Serotonin: and what about its side effects?
Richelson E
Depress Anxiety; 1998; 7 Suppl 1():18-20. PubMed ID: 9597347
[TBL] [Abstract][Full Text] [Related]
12. [Development of antidepressant drugs. Experience and prospects].
Bouvier N; Trenque T; Millart H
Presse Med; 2003 Mar; 32(11):519-22. PubMed ID: 12733393
[TBL] [Abstract][Full Text] [Related]
13. The role of dopamine and norepinephrine in depression and antidepressant treatment.
Nutt DJ
J Clin Psychiatry; 2006; 67 Suppl 6():3-8. PubMed ID: 16848670
[TBL] [Abstract][Full Text] [Related]
14. Progress in the psychopharmacology of antidepressants: selective uptake and MAO-inhibitors.
Delini-Stula A
Schweiz Arch Neurol Psychiatr (1985); 1986; 137(5):121-33. PubMed ID: 2431464
[No Abstract] [Full Text] [Related]
15. Molecular and cellular mechanisms of antidepressant drugs.
Owens MJ
Depress Anxiety; 1996-1997; 4(4):153-9. PubMed ID: 9166647
[TBL] [Abstract][Full Text] [Related]
16. Regulation of neurotransmitter receptors by desipramine and other antidepressant drugs: the neurotransmitter receptor hypothesis of antidepressant action.
Stahl SM
J Clin Psychiatry; 1984 Oct; 45(10 Pt 2):37-45. PubMed ID: 6090439
[TBL] [Abstract][Full Text] [Related]
17. The symptoms, neurobiology, and current pharmacological treatment of depression.
To SE; Zepf RA; Woods AG
J Neurosci Nurs; 2005 Apr; 37(2):102-7. PubMed ID: 15902953
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of antidepressants.
Richelson E
Psychopathology; 1987; 20 Suppl 1():1-12. PubMed ID: 2892225
[TBL] [Abstract][Full Text] [Related]
19. The monoaminergic tripartite synapse: a putative target for currently available antidepressant drugs.
Quesseveur G; Gardier AM; Guiard BP
Curr Drug Targets; 2013 Oct; 14(11):1277-94. PubMed ID: 24020973
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing roles for norepinephrine and serotonin in the behavioral effects of antidepressant drugs.
Lucki I; O'Leary OF
J Clin Psychiatry; 2004; 65 Suppl 4():11-24. PubMed ID: 15046537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
